Common pathological mechanisms in mouse models for muscular dystrophies

Duchenne/Becker and limb‐girdle muscular dystrophies share clinical symptoms like muscle weakness and wasting but differ in clinical presentation and severity. To get a closer view on the differentiating molecular events responsible for the muscular dystrophies, we have carried out a comparative gene expression profiling of hindlimb muscles of the following mouse models: dystrophin‐deficient (mdx, mdx3cv), sarcoglycan‐deficient (Sgca null, Sgcb null, Sgcg null, Sgcd null), dysferlin‐deficient (Dysf null, SJLDysf), sarcospan‐deficient (Sspn null), and wild‐type (C57Bl/6, C57Bl/10) mice. The expression profiles clearly discriminated between severely affected (dystrophinopathies and sarcoglycanopathies) and mildly or nonaffected models (dysferlinopathies, sarcospan‐deficiency, wild‐type). Dystrophin‐deficient and sarcoglycandeficient profiles were remarkably similar, sharing inflammatory and structural remodeling processes. These processes were also ongoing in dysferlin‐deficient animals, albeit at lower levels, in agreement with the later age of onset of this muscular dystrophy. The inflammatory proteins Spp1 and S100a9 were up‐regulated in all models, including sarcospan‐deficient mice, which points, for the first time, at a subtle phenotype for Sspn null mice. In conclusion, we identified biomarker genes for which expression correlates with the severity of the disease, which can be used for monitoring disease progression. This comparative study is an integrating step toward the development of an expression profiling‐based diagnostic approach for muscular dystrophies in humans.

[1]  K. Campbell,et al.  Sarcospan-Deficient Mice Maintain Normal Muscle Function , 2000, Molecular and Cellular Biology.

[2]  J. Tremblay,et al.  Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice , 1997, Neuromuscular Disorders.

[3]  Eric P. Hoffman,et al.  Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .

[4]  Eric P Hoffman,et al.  A web-accessible complete transcriptome of normal human and DMD muscle , 2002, Neuromuscular Disorders.

[5]  A. Wernig,et al.  The ontogeny of soleus muscles in mdx and wild type mice , 2005, Neuromuscular Disorders.

[6]  K. Daniels,et al.  Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. , 1997, Human molecular genetics.

[7]  J. Beckmann,et al.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.

[8]  K. Campbell,et al.  Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. , 2000, Human molecular genetics.

[9]  I. Kohane,et al.  Molecular classification of nemaline myopathies: “nontyping” specimens exhibit unique patterns of gene expression , 2004, Neurobiology of Disease.

[10]  Johan T den Dunnen,et al.  Gene expression variation between mouse inbred strains , 2004, BMC Genomics.

[11]  Kevin M Flanigan,et al.  Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. , 2003, Human molecular genetics.

[12]  M. Le Cunff,et al.  Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice. , 2002, American journal of physiology. Cell physiology.

[13]  L. Kunkel,et al.  Microarray analysis of normal and dystrophic skeletal muscle , 2002, International Journal of Developmental Neuroscience.

[14]  S. Noguchi,et al.  Dystrophin-associated proteins in muscular dystrophy. , 1995, Human molecular genetics.

[15]  P. Caroni,et al.  Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation , 1994, Cell.

[16]  P. Hoen,et al.  Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling , 2005, BMC Genomics.

[17]  V. Chapman,et al.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin , 1993, Nature Genetics.

[18]  K. Campbell,et al.  Molecular basis of muscular dystrophies , 2000, Muscle & nerve.

[19]  J. D. Porter,et al.  Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle , 2003, Neuromuscular Disorders.

[20]  M. Sharma,et al.  Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. , 2003, Magnetic resonance imaging.

[21]  S. Noguchi,et al.  From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy , 1998, Muscle & nerve.

[22]  Alexander R. Abbas,et al.  Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data , 2005, Genes and Immunity.

[23]  K. Campbell,et al.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. , 2001, The Journal of clinical investigation.

[24]  B. Hyman,et al.  Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing* , 2003, Journal of Biological Chemistry.

[25]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[26]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[27]  J. D. den Dunnen,et al.  Intensity-based analysis of two-colour microarrays enables efficient and flexible hybridization designs. , 2004, Nucleic acids research.

[28]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[29]  J. D. den Dunnen,et al.  Fluorescent labelling of cRNA for microarray applications. , 2003, Nucleic acids research.

[30]  L. Kunkel,et al.  Muscular dystrophies: genes to pathogenesis. , 2003, Current opinion in genetics & development.

[31]  Giorgio Valle,et al.  Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. , 2002, Human molecular genetics.

[32]  K. Bushby,et al.  Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B , 1999, Nature Genetics.

[33]  K. Bushby,et al.  Making sense of the limb-girdle muscular dystrophies. , 1999, Brain : a journal of neurology.

[34]  S. Carpenter,et al.  Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. , 1979, Brain : a journal of neurology.

[35]  L. Kunkel,et al.  Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Sasaoka,et al.  Analysis of the spatial, temporal and tissue‐specific transcription of γ‐sarcoglycan gene using a transgenic mouse , 2001, FEBS letters.

[37]  David Botstein,et al.  SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data , 2003, Nucleic Acids Res..

[38]  K. Campbell,et al.  Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.

[39]  J. D. Porter,et al.  Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. , 2003, Human molecular genetics.

[40]  C. Leveille,et al.  Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster. , 1998, The American journal of pathology.

[41]  K. Campbell,et al.  Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. , 2000, Molecular cell.

[42]  J. Lupski,et al.  Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.

[43]  K. Campbell,et al.  Dysferlin and the plasma membrane repair in muscular dystrophy. , 2004, Trends in cell biology.

[44]  M. Jackson,et al.  How does dystrophin deficiency lead to muscle degeneration? — Evidence from the MDX mouse , 1995, Neuromuscular Disorders.

[45]  K. Campbell,et al.  Congenital muscular dystrophy with merosin deficiency. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[46]  Bing Zhang,et al.  GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies , 2004, BMC Bioinformatics.

[47]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Tatsushi Toda,et al.  cDNA microarray analysis of individual Duchenne muscular dystrophy patients. , 2003, Human molecular genetics.

[49]  L. Maquat,et al.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.

[50]  C. Leveille,et al.  Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster , 1998 .

[51]  Kiyotoshi Kaneko,et al.  Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in γ-sarcoglycan-deficient mice , 2003, Neuromuscular Disorders.

[52]  John A. Faulkner,et al.  Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.

[53]  H. Hama,et al.  Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. , 1999, Human molecular genetics.

[54]  K. Dietzmann,et al.  Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse , 1998, Molecular and Cellular Biochemistry.

[55]  T. Tsukahara,et al.  CDNA microarray analysis of gene expression in fibroblasts of patients with x‐linked Emery–Dreifuss muscular dystrophy , 2002, Muscle & nerve.

[56]  J. D. Porter,et al.  A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.

[57]  K. Campbell,et al.  The sarcoglycan complex in limb-girdle muscular dystrophy. , 1998, Current opinion in neurology.

[58]  K. Campbell,et al.  Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. , 2002, Current opinion in genetics & development.

[59]  Chien-Chang Chen,et al.  Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.